EMA recommends approval for use of RoActemra in adults with severe COVID-19

Alles was mit dem Corona-Virus bzw. CoViD19 zu tun hat - nach Abebben der Pandemie wird das Forum deaktiviert und ins Archiv geschoben.
Antworten
Administrator
Site Admin
Beiträge: 723
Registriert: Do Mai 31, 2018 9:27 pm

EMA recommends approval for use of RoActemra in adults with severe COVID-19

Beitrag von Administrator » Mo Dez 06, 2021 5:49 pm

https://www.ema.europa.eu/en/news/ema-recommends-approval-use-roactemra-adults-severe-covid-19
The medicine, marketed by Roche Registration GmbH, is already approved in the EU for treating the inflammatory conditions rheumatoid arthritis, systemic juvenile idiopathic arthritis, juvenile idiopathic polyarthritis, giant cell arteritis and cytokine release syndrome (CRS).

Antworten